Bing Jie Chow
Research Subjects
Research Interests
Bing Jie Chow has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Arjun Nathan
Department of Health Services Research and Policy London School of Hygiene and Tropical Medicine London UK
2 shared publications - Nikita Rajiv Bhatt
Department of Urology, St. Vincent's Healthcare Group, Elm Park, Dublin 4, Ireland.
2 shared publications Adrian Chi‐Heng Fung
Department of Surgery, School of Clinical Medicine, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong Hong Kong
1 shared publication- Alexander Light
Imperial Prostate, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK
1 shared publication Alexander Ng
British Urology Researchers in Surgical Training (BURST) London UK
1 shared publicationAndrés Salas
Hospital de Oncología Centro Médico Nacional ‘Siglo XXI’ Mexico Mexico
1 shared publication
Latest Publications
- Open Access
- 31 January 2025
- Published by Wiley in BJU International
- Vol. 135 (5) , 717-719
Global comparison of research ethical review protocols: insights from an international research collaborative
- 31 January 2025
- Published by Wiley in BJU International
- Vol. 135 (5) , 717-719
Open AccessGlobal comparison of research ethical review protocols: insights from an international research collaborative
- Open Access
- 8 January 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (1) , 45
The Application of Terahertz Technology in Corneas and Corneal Diseases: A Systematic Review
Terahertz (THz) waves reside in the electromagnetic spectrum between the microwave and infrared bands. In recent decades, THz technology has demonstrated its potential for biomedical applications. With the highly unique characteristics of THz waves, such as the high sensitivity to water and optimal spatial resolution coupled with the characteristics of the human cornea, such as its high water content, THz technology has been explored as a potential modality to assess corneas and corneal diseases. This systematic review provides an overview of the characteristics of THz waves, the safety profile of THz technology in the field of ophthalmology, and its clinical applications, including the objective evaluation of the corneal hydration, tear film, dry eye disease, corneal endothelium, corneal elasticity, and scarring. The paper also presents our viewpoint on the present challenges and future directions of THz technology prior to its broader integration into clinical practice.
- 8 January 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (1) , 45
Open AccessThe Application of Terahertz Technology in Corneas and Corneal Diseases: A Systematic Review
Terahertz (THz) waves reside in the electromagnetic spectrum between the microwave and infrared bands. In recent decades, THz technology has demonstrated its potential for biomedical applications. With the highly unique characteristics of THz waves, such as the high sensitivity to water and optimal spatial resolution coupled with the characteristics of the human cornea, such as its high water content, THz technology has been explored as a potential modality to assess corneas and corneal diseases. This systematic review provides an overview of the characteristics of THz waves, the safety profile of THz technology in the field of ophthalmology, and its clinical applications, including the objective evaluation of the corneal hydration, tear film, dry eye disease, corneal endothelium, corneal elasticity, and scarring. The paper also presents our viewpoint on the present challenges and future directions of THz technology prior to its broader integration into clinical practice.
- 17 October 2024
- Published by Wiley in BJU International
- Vol. 135 (1) , 3-5
Recent advancements in the Ward AdmSsion of Haematuria: an Observational mUlticentre sTudy ( WASHOUT) —a large‐scale observational multicentre study of inpatient haematuria
- 17 October 2024
- Published by Wiley in BJU International
- Vol. 135 (1) , 3-5
Recent advancements in the Ward AdmSsion of Haematuria: an Observational mUlticentre sTudy ( WASHOUT) —a large‐scale observational multicentre study of inpatient haematuria
- 20 March 2023
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 25 (4) , 1293-1300
Management of infected arteriovenous grafts for haemodialysis: Outcomes and strategies using a novel objective scoring system
Background: In haemodialysis patients with exhausted autogenous options, prosthetic arteriovenous grafts (AVGs) are frequently utilised as tertiary vascular access. However, the prosthetic nature of AVGs precipitates an increased risk of infection which may translate to excess morbidity and life-threatening complications. The current evidence remains divided on the optimal treatment strategy for arteriovenous graft infections (AVGi) with arguments for conservative management by antibiotics, salvaging with graft revision or total/subtotal excision. To address this gap, we assessed the outcomes of AVGi patients treated in our institution, developing an AVGi severity classification model and a proposed treatment algorithm to guide AVGi management. Methods: We conducted a single centre retrospective review of outcomes of patients with AVGi managed either by sole antibiotics therapy, graft revision or surgical excision between June 2016 and May 2021. Outcomes of AVGi patients across differing treatment groups were compared, including 1-year mortality, 6-month and 1-year functional vascular access. We also analysed the outcomes of tunnelled haemodialysis lines (THL), which were used as a temporary vascular access in several AVGi patients in our study. Results: A total of 34 AVGi patients were managed within that time frame and included in the study (5 conservatively management by antibiotics, 5 graft revisions and 24 surgical excision) with a mean age of 60.4 ± 14.4 years (67.6% males). Overall 1-year mortality was 14.7%. A 6-month functional vascular access status across the three groups stood at 60%, 60% and 10% while 1-year functional vascular access status was 60%, 75% and 42% respectively. Conclusions: When clinically appropriate, conservative management by antibiotics or salvage/graft revision can present as prudent AVGi treatment options. The adoption of our proposed severity classification system and treatment algorithm provides a more thorough objective assessment of the infection and helps guide the clinical decision-making process.
- 20 March 2023
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 25 (4) , 1293-1300
Management of infected arteriovenous grafts for haemodialysis: Outcomes and strategies using a novel objective scoring system
Background: In haemodialysis patients with exhausted autogenous options, prosthetic arteriovenous grafts (AVGs) are frequently utilised as tertiary vascular access. However, the prosthetic nature of AVGs precipitates an increased risk of infection which may translate to excess morbidity and life-threatening complications. The current evidence remains divided on the optimal treatment strategy for arteriovenous graft infections (AVGi) with arguments for conservative management by antibiotics, salvaging with graft revision or total/subtotal excision. To address this gap, we assessed the outcomes of AVGi patients treated in our institution, developing an AVGi severity classification model and a proposed treatment algorithm to guide AVGi management. Methods: We conducted a single centre retrospective review of outcomes of patients with AVGi managed either by sole antibiotics therapy, graft revision or surgical excision between June 2016 and May 2021. Outcomes of AVGi patients across differing treatment groups were compared, including 1-year mortality, 6-month and 1-year functional vascular access. We also analysed the outcomes of tunnelled haemodialysis lines (THL), which were used as a temporary vascular access in several AVGi patients in our study. Results: A total of 34 AVGi patients were managed within that time frame and included in the study (5 conservatively management by antibiotics, 5 graft revisions and 24 surgical excision) with a mean age of 60.4 ± 14.4 years (67.6% males). Overall 1-year mortality was 14.7%. A 6-month functional vascular access status across the three groups stood at 60%, 60% and 10% while 1-year functional vascular access status was 60%, 75% and 42% respectively. Conclusions: When clinically appropriate, conservative management by antibiotics or salvage/graft revision can present as prudent AVGi treatment options. The adoption of our proposed severity classification system and treatment algorithm provides a more thorough objective assessment of the infection and helps guide the clinical decision-making process.